Canada - Toronto Stock Exchange - TSX:HEXO - CA4283044069 - Common Stock
The current stock price of HEXO.CA is 0.88 CAD. In the past month the price decreased by -37.59%. In the past year, price decreased by -76.72%.
ChartMill assigns a fundamental rating of 2 / 10 to HEXO.CA. HEXO.CA may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months HEXO.CA reported a non-GAAP Earnings per Share(EPS) of -40.48. The EPS increased by 90.82% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.01 |
12 analysts have analysed HEXO.CA and the average price target is 1.64 CAD. This implies a price increase of 86.9% is expected in the next year compared to the current price of 0.88.
For the next year, analysts expect an EPS growth of 99.88% and a revenue growth -42.24% for HEXO.CA
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BHC.CA | BAUSCH HEALTH COS INC | 1.83 | 3.61B | ||
| TLRY.CA | TILRAY BRANDS INC | N/A | 1.53B | ||
| CRON.CA | CRONOS GROUP INC | 23.53 | 1.35B | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 6.98 | 865.23M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 607.96M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | N/A | 586.80M | ||
| NGEN.CA | NERVGEN PHARMA CORP | N/A | 564.21M | ||
| TSND.CA | TERRASCEND CORP | N/A | 412.44M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 16.74 | 390.70M | ||
| ACB.CA | AURORA CANNABIS INC | N/A | 331.70M | ||
| HITI.CA | HIGH TIDE INC | N/A | 311.48M | ||
| OGI.CA | ORGANIGRAM GLOBAL INC | N/A | 300.90M |
HEXO Corp. engages in the provision of cannabis and cannabis products. The company is headquartered in Kanata, Ontario and currently employs 689 full-time employees. The company went IPO on 2014-11-17. The firm is engaged in cultivating, processing, packaging, and distributing cannabis products to serve the cannabis market. The firm serves the Canadian recreational market with a brand portfolio, including HEXO, Redecan, UP Cannabis, Original Stash, 48North, Trail Mix, Bake Sale and Latitude brands, and the medical market under HEXO medical cannabis in Canada and Israel. Its HEXO brand offers a range of flower strains, discreet capsules, and convenient vapes, including the HEXO FLVR lineup of flavor-first vapes, and HEXO Plus high potency flower, exclusive to Quebec. Its brand Namaste is a recreational cannabis brand for mindful consumers.
HEXO Corp
3000 Solandt Rd,
Kanata ONTARIO K2K 2X2 CA
CEO: Scott Cooper
Employees: 689
Phone: 18664388429.0
HEXO Corp. engages in the provision of cannabis and cannabis products. The company is headquartered in Kanata, Ontario and currently employs 689 full-time employees. The company went IPO on 2014-11-17. The firm is engaged in cultivating, processing, packaging, and distributing cannabis products to serve the cannabis market. The firm serves the Canadian recreational market with a brand portfolio, including HEXO, Redecan, UP Cannabis, Original Stash, 48North, Trail Mix, Bake Sale and Latitude brands, and the medical market under HEXO medical cannabis in Canada and Israel. Its HEXO brand offers a range of flower strains, discreet capsules, and convenient vapes, including the HEXO FLVR lineup of flavor-first vapes, and HEXO Plus high potency flower, exclusive to Quebec. Its brand Namaste is a recreational cannabis brand for mindful consumers.
The current stock price of HEXO.CA is 0.88 CAD. The price increased by 1.15% in the last trading session.
HEXO.CA does not pay a dividend.
HEXO.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
HEXO Corp (HEXO.CA) currently has 689 employees.
HEXO Corp (HEXO.CA) has a market capitalization of 38.18M CAD. This makes HEXO.CA a Nano Cap stock.